Brígida Riso

Dr. Brígida Riso

Faculdade de Medicina da Universidade de Lisboa, Lisbon, Lisboa, Portugal
+2
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2017 in Journal of Community Genetics
Verified
Journal Article
Open access
PDF file
PBPascal Borry
Pascal Borry
HBHeidi Beate Bentzen
Heidi Beate Bentzen
IBIsabelle Budin-Ljøsne
Isabelle Budin-Ljøsne
MCMartina C. Cornel
Martina C. Cornel
HHHeidi Carmen Howard
Heidi Carmen Howard
HFHeike Felzmann
Heike Felzmann
Rapid advances in microarray and sequencing technologies are making genotyping and genome sequencing more affordable and readily available. There is an expectation that genomic sequencing technologies improve personalized diagnosis and personalized drug therapy. Concurrently, provision of direct-to-consumer genetic testing by commercial providers has enabled individuals’ direct access to their genomic data. The expanded availability of genomic data is perceived as influencing the relationship between the various parties involved including healthcare professionals, researchers, patients, individuals, families, industry, and government. This results in a need to revisit their roles and responsibilities. In a 1-day agenda-setting meeting organized by the COST Action IS1303 “Citizen’s Health through public-private Initiatives: Public health, Market and Ethical perspectives,” participants discussed the main challenges associated with the expanded availability of genomic information, with a specific focus on public-private partnerships, and provided an outline from which to discuss in detail the identified challenges. This paper summarizes the points raised at this meeting in five main parts and highlights the key cross-cutting themes. In light of the increasing availability of genomic information, it is expected that this paper will provide timely direction for future research and policy making in this area.

21 August 2017 in Life Sciences, Society and Policy
Verified
Journal Article
Open access
PDF file
BRBrígida Riso
Brígida Riso
ATAaro Tupasela
Aaro Tupasela
DVDanya F Vears
Danya F Vears
HFHeike Felzmann
Heike Felzmann
JCJulian Cockbain
Julian Cockbain
VRVojin Rakic
Vojin Rakic
Intensified and extensive data production and data storage are characteristics of contemporary western societies. Health data sharing is increasing with the growth of Information and Communication Technology (ICT) platforms devoted to the collection of personal health and genomic data. However, the sensitive and personal nature of health data poses ethical challenges when data is disclosed and shared even if for scientific research purposes. With this in mind, the Science and Values Working Group of the COST Action CHIP ME ‘Citizen's Health through public-private Initiatives: Public health, Market and Ethical perspectives’ (IS 1303) identified six core values they considered to be essential for the ethical sharing of health data using ICT platforms. We believe that using this ethical framework will promote respectful scientific practices in order to maintain individuals’ trust in research. We use these values to analyse five ICT platforms and explore how emerging data sharing platforms are reconfiguring the data sharing experience from a range of perspectives. We discuss which types of values, rights and responsibilities they entail and enshrine within their philosophy or outlook on what it means to share personal health information. Through this discussion we address issues of the design and the development process of personal health data and patient-oriented infrastructures, as well as new forms of technologically-mediated empowerment.

24 October 2017 in Journal of Community Genetics
Verified
Journal Article
Open access
PDF file
OFOliver Feeney
Oliver Feeney
PBPascal Borry
Pascal Borry
HFHeike Felzmann
Heike Felzmann
LGLucia Galvagni
Lucia Galvagni
AHAri Haukkala
Ari Haukkala
DVDanya Vears
Danya Vears
The introduction of Web 2.0 technology, along with a population increasingly proficient in Information and Communications Technology (ICT), coupled with the rapid advancements in genetic testing methods, has seen an increase in the presence of participant-centred research initiatives. Such initiatives, aided by the centrality of ICT interconnections, and the ethos they propound seem to further embody the ideal of increasing the participatory nature of research, beyond what might be possible in non-ICT contexts alone. However, the majority of such research seems to actualise a much narrower definition of ‘participation’—where it is merely the case that such research initiatives have increased contact with participants through ICT but are otherwise non-participatory in any important normative sense. Furthermore, the rhetoric of participant-centred initiatives tends to inflate this minimalist form of participation into something that it is not, i.e. something genuinely participatory, with greater connections with both the ICT-facilitated political contexts and the largely non-ICT participatory initiatives that have expanded in contemporary health and research contexts. In this paper, we highlight that genuine (ICT-based) ‘participation’ should enable a reasonable minimum threshold of participatory engagement through, at least, three central participatory elements: educative, sense of being involved and degree of control. While we agree with criticisms that, at present, genuine participation seems more rhetoric than reality, we believe that there is clear potential for a greater ICT-facilitated participatory engagement on all three participatory elements. We outline some practical steps such initiatives could take to further develop these elements and thereby their level of ICT-facilitated participatory engagement.

6 August 2022 in Societies
Verified
Journal Article
Open access
PDF file
BRBrígida Riso
Brígida Riso
Biobanks have been established from the beginning of the millennium as relevant infrastructures to support biomedical research. These repositories have also transformed the paradigm of collecting and storing samples and associated clinical data, moving these practices from the healthcare services and research laboratories to dedicated services. In Portugal, the establishment of biobanks is happening in the absence of a specific legal framework, turning it difficult to fully understand the scope of their action. This ethnographic research explored how establishing a biobank challenges the dynamics between healthcare and biomedical research. The ethnography intended to follow the path of biological samples from the hospital, where they were collected, to the biobank in a research institute, where they were stored. Findings suggest that although the nature of the biobank’s technical work seemed to inscribe it as a research-oriented setting, the biobank’s daily work was performed through symbolic action in the logic of care. Biobank staff constantly recalled the human nature of the samples, and they built complex illness narratives of each sample, promoting a connection with the absent donor. These practices were crucial to constructing the biobank as a health place, one that was designed to be life-saving in the near future.

9 August 2024 in SciELO Preprints
Verified
Preprint
Open access
BRBrígida Riso
Brígida Riso
Os biobancos são repositórios de amostras biológicas humanas associadas a registos médicos, recolhidos de forma sistemática, para serem utilizados em investigação biomédica. Apesar de comum as práticas de colecionismo médico e por parte dos investigadores das ciências da vida, o crescimento destas atividades veio trazer para o debate as questões sociais, éticas e legais da recolha e armazenamento de “partes do corpo” e amostras biológicas a serem utilizadas em investigação. Neste artigo, pretende-se explorar os sentidos sociais e simbólicos atribuídos ao corpo no contexto da recolha e armazenamento de amostras biológicas para investigação – como este é conceptualizado, organizado e vigiado, bem como a que atores e que referencias se encontram por detrás dessa organização. Deste modo, a partir de uma análise da legislação com recurso a CAQDAS (Computer Assisted Qualitative Data Analysis Software) foi possível explorar o corpo como uma fornte de dados biológicos e informacionais, que se constitui como um objeto médico-científico necessário à produção de saber médico. Apesar da salvaguarda dos direitos dos dadores de amostras biológicas, o protagonismo da medicina é evidente quer na conceção do corpo, quer na sua administração.

15 February 2023 in Science & Technology Studies
Verified
Journal Article
Open access
PDF file
BRBrígida Riso
Brígida Riso